BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 31050249)

  • 21. Comparison of two interferon gamma release assays in the diagnosis of Mycobacterium tuberculosis infection and disease in The Gambia.
    Adetifa IM; Lugos MD; Hammond A; Jeffries D; Donkor S; Adegbola RA; Hill PC
    BMC Infect Dis; 2007 Oct; 7():122. PubMed ID: 17961228
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Performance of Interferon-γ Release Assays in Patients with
    Gao CH; Zhang YA; Wang MS
    Infect Drug Resist; 2022; 15():7727-7732. PubMed ID: 36597452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interferon gamma release assays: principles and practice.
    Lalvani A; Pareek M
    Enferm Infecc Microbiol Clin; 2010 Apr; 28(4):245-52. PubMed ID: 19783328
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Position statement on interferon-γ release assays for the detection of latent tuberculosis infection.
    Bastian I; Coulter C;
    Commun Dis Intell Q Rep; 2017 Dec; 41(4):E322-E336. PubMed ID: 29864386
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Frequently Isolated Slow Growing Nontuberculous Mycobacteria from Pulmonary Samples and Evaluation of Drug Susceptibility Testing Results in a Referral Hospital in Turkey].
    Ceyhan İ; Özkara Ş; Güler MZ; Dulkar G; Altınsoy R; Vezir S
    Mikrobiyol Bul; 2019 Jul; 53(3):330-335. PubMed ID: 31414634
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Two-Step Real-Time PCR Method To Identify Mycobacterium tuberculosis Infections and Six Dominant Nontuberculous Mycobacterial Infections from Clinical Specimens.
    Park J; Kwak N; Chae JC; Yoon EJ; Jeong SH
    Microbiol Spectr; 2023 Aug; 11(4):e0160623. PubMed ID: 37378523
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kinetics of a tuberculosis-specific gamma interferon release assay in military personnel with a positive tuberculin skin test.
    van Brummelen SE; Bauwens AM; Schlösser NJ; Arend SM
    Clin Vaccine Immunol; 2010 Jun; 17(6):937-43. PubMed ID: 20375241
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New tools for detecting latent tuberculosis infection: evaluation of RD1-specific long-term response.
    Butera O; Chiacchio T; Carrara S; Casetti R; Vanini V; Meraviglia S; Guggino G; Dieli F; Vecchi M; Lauria FN; Marruchella A; Laurenti P; Singh M; Caccamo N; Girardi E; Goletti D
    BMC Infect Dis; 2009 Nov; 9():182. PubMed ID: 19930588
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Higher-than-expected prevalence of non-tuberculous mycobacteria in HIV setting in Botswana: Implications for diagnostic algorithms using Xpert MTB/RIF assay.
    Agizew T; Basotli J; Alexander H; Boyd R; Letsibogo G; Auld A; Nyirenda S; Tedla Z; Mathoma A; Mathebula U; Pals S; Date A; Finlay A
    PLoS One; 2017; 12(12):e0189981. PubMed ID: 29272273
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tuberculosis Infection in Children and Adolescents: Testing and Treatment.
    Nolt D; Starke JR
    Pediatrics; 2021 Dec; 148(6):. PubMed ID: 34851422
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tuberculin skin testing and treatment modulates interferon-gamma release assay results for latent tuberculosis in migrants.
    O'Shea MK; Fletcher TE; Beeching NJ; Dedicoat M; Spence D; McShane H; Cunningham AF; Wilson D
    PLoS One; 2014; 9(5):e97366. PubMed ID: 24816576
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Evaluation of the distribution of non-tuberculous mycobacteria strains isolated in National Tuberculosis Reference Laboratory in 2009-2010, Turkey].
    Albayrak N; Simşek H; Sezen F; Arslantürk A; Tarhan G; Ceyhan I
    Mikrobiyol Bul; 2012 Oct; 46(4):560-7. PubMed ID: 23188570
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Characteristics of a diagnostic method for tuberculosis infection based on whole blood interferon-gamma assay].
    Harada N
    Kekkaku; 2006 Nov; 81(11):681-6. PubMed ID: 17154047
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of two interferon-gamma release assays (QuantiFERON-TB Gold In-Tube and T-SPOT.TB) in testing for latent tuberculosis infection among HIV-infected adults.
    Sultan B; Benn P; Mahungu T; Young M; Mercey D; Morris-Jones S; Miller RF
    Int J STD AIDS; 2013 Oct; 24(10):775-9. PubMed ID: 23970606
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The performance of interferon gamma release assays in patients with nontuberculous mycobacterial infection: a systematic review and meta-analysis.
    Guan CP; Wu YH; Wang XF; He Y; Zhang YA; Wang MS
    Eur J Clin Microbiol Infect Dis; 2023 Oct; 42(10):1251-1262. PubMed ID: 37702955
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Accuracy of QuantiFERON in active tuberculosis suspects with comorbidities and nontuberculous mycobacterial infection in Northern California.
    Lu J; Murugesan K; Senchyna F; Budvytiene I; Banaei N
    J Clin Microbiol; 2023 Nov; 61(11):e0077523. PubMed ID: 37843251
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prospective comparison of the tuberculin skin test and 2 whole-blood interferon-gamma release assays in persons with suspected tuberculosis.
    Mazurek GH; Weis SE; Moonan PK; Daley CL; Bernardo J; Lardizabal AA; Reves RR; Toney SR; Daniels LJ; LoBue PA
    Clin Infect Dis; 2007 Oct; 45(7):837-45. PubMed ID: 17806047
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contribution of a heparin-binding haemagglutinin interferon-gamma release assay to the detection of Mycobacterium tuberculosis infection in HIV-infected patients: comparison with the tuberculin skin test and the QuantiFERON-TB Gold In-tube.
    Wyndham-Thomas C; Dirix V; Schepers K; Martin C; Hildebrand M; Goffard JC; Domont F; Libin M; Loyens M; Locht C; Van Vooren JP; Mascart F
    BMC Infect Dis; 2015 Feb; 15():59. PubMed ID: 25886172
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical presentations of nontuberculous mycobacteria as suspected and drug-resistant tuberculosis: Experience from a tertiary care center in Eastern India.
    Das S; Mishra B; Mohapatra PR; Preetam C; Rath S
    Int J Mycobacteriol; 2022; 11(2):167-174. PubMed ID: 35775549
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of purified protein derivative mycobacterial skin test antigens in children and adolescents: purified protein derivative skin test results correlated with mycobacterial isolates.
    Margileth AM
    Pediatr Infect Dis; 1983; 2(3):225-31. PubMed ID: 6408620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.